These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19227896)

  • 21. Variable course of Unverricht-Lundborg disease: Early prognostic factors.
    Canafoglia L; Ferlazzo E; Michelucci R; Striano P; Magaudda A; Gambardella A; Pasini E; Belcastro V; Riguzzi P; Fanella M; Granata T; Beccaria F; Trentini C; Bianchi A; Aguglia U; Panzica F; Franceschetti S
    Neurology; 2017 Oct; 89(16):1691-1697. PubMed ID: 28931642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new clinical and molecular form of Unverricht-Lundborg disease localized by homozygosity mapping.
    Berkovic SF; Mazarib A; Walid S; Neufeld MY; Manelis J; Nevo Y; Korczyn AD; Yin J; Xiong L; Pandolfo M; Mulley JC; Wallace RH
    Brain; 2005 Mar; 128(Pt 3):652-8. PubMed ID: 15634728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unverricht-Lundborg disease, a condition with self-limited progression: long-term follow-up of 20 patients.
    Magaudda A; Ferlazzo E; Nguyen VH; Genton P
    Epilepsia; 2006 May; 47(5):860-6. PubMed ID: 16686650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Negative myoclonus causes locomotory disability in progressive myoclonus epilepsy type EPM1- Unverricht-Lundborg disease.
    Vogt H; Baisch T; Mueller-Pfeiffer C; Mothersill IW
    Epileptic Disord; 2023 Jun; 25(3):297-308. PubMed ID: 37536959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unverricht-Lundborg disease.
    Crespel A; Ferlazzo E; Franceschetti S; Genton P; Gouider R; Kälviäinen R; Korja M; Lehtinen MK; Mervaala E; Simonato M; Vaarmann A
    Epileptic Disord; 2016 Sep; 18(S2):28-37. PubMed ID: 27582036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs.
    Lucchino V; Scaramuzzino L; Scalise S; Lo Conte M; Zannino C; Benedetto GL; Aguglia U; Ferlazzo E; Cuda G; Parrotta EI
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimyoclonic effect of levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations.
    Magaudda A; Gelisse P; Genton P
    Epilepsia; 2004 Jun; 45(6):678-81. PubMed ID: 15144434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Univerricht-Lundborg disease: underdiagnosed in the Netherlands.
    de Haan GJ; Halley DJ; Doelman JC; Geesink HH; Augustijn PB; Jager-Jongkind AD; Majoie M; Bader AJ; Leliefeld-Ten Doeschate LA; Deelen WH; Bertram E; Lehesjoki AE; Lindhout D
    Epilepsia; 2004 Sep; 45(9):1061-3. PubMed ID: 15329070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychological findings in patients with Unverricht-Lundborg disease.
    Ferlazzo E; Gagliano A; Calarese T; Magaudda A; Striano P; Cortese L; Cedro C; Laguitton V; Bramanti P; Carbonaro M; Albachiara A; Fragassi N; Italiano D; Sessa E; Coppola A; Genton P
    Epilepsy Behav; 2009 Mar; 14(3):545-9. PubMed ID: 19185615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease.
    Lucchino V; Scaramuzzino L; Scalise S; Grillone K; Lo Conte M; Esposito C; Aguglia U; Ferlazzo E; Perrotti N; Malatesta P; Parrotta EI; Cuda G
    Stem Cell Res; 2021 May; 53():102329. PubMed ID: 33865103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difficult differential diagnosis of Unverricht-Lundborg disease with spontaneous kinesogenic myoclonus and movement disorder.
    Rana AQ; Ali A; Böke BN
    Acta Neurol Belg; 2012 Dec; 112(4):383-4. PubMed ID: 22539245
    [No Abstract]   [Full Text] [Related]  

  • 32. Polymerase chain reaction-based analysis using deaminated DNA of dodecamer expansions in CSTB, associated with Unverricht-Lundborg myoclonus epilepsy.
    Horiuchi H; Osawa M; Furutani R; Morita M; Tian W; Awatsu Y; Shimazaki H; Umetsu K
    Genet Test; 2005; 9(4):328-33. PubMed ID: 16379547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary motor cortex alterations in a compound heterozygous form of Unverricht-Lundborg disease (EPM1).
    Danner N; Julkunen P; Könönen M; Hyppönen J; Koskenkorva P; Vanninen R; Lehesjoki AE; Kälviäinen R; Mervaala E
    Seizure; 2011 Jan; 20(1):65-71. PubMed ID: 21075014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study.
    Hyppönen J; Äikiä M; Joensuu T; Julkunen P; Danner N; Koskenkorva P; Vanninen R; Lehesjoki AE; Mervaala E; Kälviäinen R
    Neurology; 2015 Apr; 84(15):1529-36. PubMed ID: 25770194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perampanel in 12 patients with Unverricht-Lundborg disease.
    Crespel A; Gelisse P; Tang NP; Genton P
    Epilepsia; 2017 Apr; 58(4):543-547. PubMed ID: 28166365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A shared haplotype indicates a founder event in Unverricht-Lundborg disease patients from Serbia.
    Kecmanović M; Ristić AJ; Ercegovac M; Keckarević-Marković M; Keckarević D; Sokić D; Romac S
    Int J Neurosci; 2014 Feb; 124(2):102-9. PubMed ID: 23883076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure.
    Dibbens LM; Michelucci R; Gambardella A; Andermann F; Rubboli G; Bayly MA; Joensuu T; Vears DF; Franceschetti S; Canafoglia L; Wallace R; Bassuk AG; Power DA; Tassinari CA; Andermann E; Lehesjoki AE; Berkovic SF
    Ann Neurol; 2009 Oct; 66(4):532-6. PubMed ID: 19847901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of motor cortical excitability and anatomy in Unverricht-Lundborg disease.
    Danner N; Julkunen P; Hyppönen J; Niskanen E; Säisänen L; Könönen M; Koskenkorva P; Vanninen R; Kälviäinen R; Mervaala E
    Mov Disord; 2013 Nov; 28(13):1860-7. PubMed ID: 23925991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giant SEPs and SEP-recovery function in Unverricht-Lundborg disease.
    Visani E; Canafoglia L; Rossi Sebastiano D; Agazzi P; Panzica F; Scaioli V; Ciano C; Franceschetti S
    Clin Neurophysiol; 2013 May; 124(5):1013-8. PubMed ID: 23276489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substantial thalamostriatal dopaminergic defect in Unverricht-Lundborg disease.
    Korja M; Kaasinen V; Lamusuo S; Parkkola R; Någren K; Marttila RJ
    Epilepsia; 2007 Sep; 48(9):1768-1773. PubMed ID: 17484752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.